← Back to Clinical Trials
Recruiting NCT06658327

NCT06658327 Comparative Effects Of Dynamic And Static Stretching In Postmenopausal Females With Knee Osteoarthritis

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06658327
Status Recruiting
Phase
Sponsor Riphah International University
Condition Postmenopausal
Study Type INTERVENTIONAL
Enrollment 58 participants
Start Date 2024-04-24
Primary Completion 2024-11-30

Eligibility & Interventions

Sex Female only
Min Age 50 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Dynamic stretchingStatic stretching

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 58 participants in total. It began in 2024-04-24 with a primary completion date of 2024-11-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

As the aging population continues to grow, there is a pressing need to explore effective interventions to alleviate the symptoms of osteoarthritis, particularly in postmenopausal women who may experience unique challenges. Osteoarthritis (OA) is progressive joint disease characterized by joint inflammation and a reparative bone response and is one of the top five most disabling conditions that affects more than one-third of persons \>65 years of age, commonly affecting hands, feet, spine, hips, and knees. Among the various therapeutic modalities, stretching exercises, both dynamic and static, have gained attention for their potential to enhance joint flexibility, reduce pain, and improve functional outcomes.

Eligibility Criteria

Inclusion Criteria: * Age 50 to 65 * Diagnosed patients of OA with grade 3 * Multiparous (5 children) * Fertile females * Pain greater than 6 on NPRS Exclusion Criteria: * BMI \> 30 * Early menarche ≤10 or 11 years. * Cancer i.e breast cancer ,Ovrian cancer * Any bone deformity before menopause i.e limb length discrepancy, angulation

Contact & Investigator

Central Contact

Adeela Arif, Mphil

✉ adeela.arif@riphah.edu.pk

📞 03320845723

Principal Investigator

Tanzeela Majeed, MS

PRINCIPAL INVESTIGATOR

Ripah International university, Lahore

Frequently Asked Questions

Who can join the NCT06658327 clinical trial?

This trial is open to female participants only, aged 50 Years or older, up to 65 Years, studying Postmenopausal. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06658327 currently recruiting?

Yes, NCT06658327 is actively recruiting participants. Contact the research team at adeela.arif@riphah.edu.pk for enrollment information.

Where is the NCT06658327 trial being conducted?

This trial is being conducted at Lahore, Pakistan.

Who is sponsoring the NCT06658327 clinical trial?

NCT06658327 is sponsored by Riphah International University. The principal investigator is Tanzeela Majeed, MS at Ripah International university, Lahore. The trial plans to enroll 58 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology